Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
777,034
-
Share change
-
+693,031
-
Total reported value
-
$1,820,000
-
Price per share
-
$2.34
-
Number of holders
-
12
-
Value change
-
+$1,623,000
-
Number of buys
-
11
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q4 2019
As of 31 Dec 2019,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
777,034 shares.
The largest 10 holders included
Linden Advisors LP, RENAISSANCE TECHNOLOGIES LLC, 683 Capital Management, LLC, Johnson & Johnson Innovation - JJDC, Inc., Telemetry Investments, L.L.C., CITADEL ADVISORS LLC, VANGUARD GROUP INC, A.R.T. Advisors, LLC, BlackRock Inc., and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.